Constitutional Law,
Government
Aug. 1, 2024
Project 2025: How a new plan could shape federal abortion prosecutions
One of the most troubling aspects of Project 2025 is its proposal for the DOJ to intensify enforcement of the Comstock Act against abortion pill providers, highlighting a potential shift in federal enforcement priorities.
In Food and Drug Administration, et al. v. Alliance for Hippocratic Medicine, et al., the plaintiffs (four pro-life medical associations and several individual doctors) moved for a preliminary injunction to require the FDA to rescind the approval of the abortion drug mifepristone or rescind its 2016 and 2021 regulatory actions. The Supreme Court held that the plaintiffs lacked Article III standing to challenge the FDA's actions (602 U.S. 36...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In